510(k) Report

510(k) · Cleared

Cleared

Arthrocare Nasastent CMC Nasal Dressing

K140992510(k) TraditionalCleared Jun 16, 201460-day reviewClass I21 CFR 874.4780

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

ArthroCare Corporation · LYA Splint, Intranasal Septal

Cleared on Jun 16, 2014 as substantially equivalent to K113585 (Cogent Therapeutics, LLC, 2012) and 1 other predicate after a 60-day review. Its family tree reaches back 5 generations to 1982.

Decided
Jun 16, 2014
Review
60 days
Class
Class I
Product code
LYA
Recalls
None
Predicates
2

Its longest line of descent runs back 5 generations to K821150 (1982). 18 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2005: 1 other ancestor2004: 1 other ancestor2001: 2 other ancestors2000: 2 other ancestors1999: 1 other ancestor1997: 3 other ancestors1993: 1 other ancestor1992: 1 other ancestor1991: 1 other ancestorK821150 · NU-Gauze Sponge · Johnson & Johnson Professionals, Inc. · 1982K984069 · Entaxis Nasal Packing · Les Laboratorires Brothier, S.A. · 1999K993362 · Hylasine · Biomatrix, Inc. · 2000K043035 · Sepragel Ent Bioresorbable Packing/Stent · Genzyme Corporation · 2005K113585 · Nasal/Epistaxis Pack · Cogent Therapeutics, LLC · 201219801985199019952000200520102015
Other ancestors, by generation 1 generation back: 1 other ancestor2 generations back: 5 other ancestors3 generations back: 3 other ancestors4 generations back: 1 other ancestor5 generations back: 3 other ancestors K113585 · Nasal/Epistaxis Pack · Cogent Therapeutics, LLC · 2012K043035 · Sepragel Ent Bioresorbable Packing/Stent · Genzyme Corporation · 2005K993362 · Hylasine · Biomatrix, Inc. · 2000K984069 · Entaxis Nasal Packing · Les Laboratorires Brothier, S.A. · 1999K821150 · NU-Gauze Sponge · Johnson & Johnson Professionals, Inc. · 1982−50
  1. Root · 5 generations backK821150 NU-Gauze SpongeJohnson & Johnson Professionals, Inc. · 1982
  2. 4 generations backK984069 Entaxis Nasal PackingLes Laboratorires Brothier, S.A. · 1999
  3. 3 generations backK993362 HylasineBiomatrix, Inc. · 2000
  4. 2 generations backK043035 Sepragel Ent Bioresorbable Packing/StentGenzyme Corporation · 2005
  5. 1 generation backK113585 Nasal/Epistaxis PackCogent Therapeutics, LLC · 2012
  6. This deviceK140992 Arthrocare Nasastent CMC Nasal DressingArthroCare Corporation · 2014
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K821150NU-Gauze SpongeJohnson & Johnson Professionals, Inc.1982—
−4K984069Entaxis Nasal PackingLes Laboratorires Brothier, S.A.1999—
−3K993362HylasineBiomatrix, Inc.2000—
−2K043035Sepragel Ent Bioresorbable Packing/StentGenzyme Corporation2005—
−1K113585Nasal/Epistaxis PackCogent Therapeutics, LLC2012—
0 (this device)K140992Arthrocare Nasastent CMC Nasal DressingArthroCare Corporation2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
199210
199310
199730
199910
200020
200120
200410
200510
FIG. 1 — Lineage of K140992, 1982–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LYA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LYA device

  1. #1 K243655 TurbAlignscore 10.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K113585Nasal/Epistaxis PackCogent Therapeutics, LLC2012—
*K052099Nasopore Nasal Dressing, Model Ndox-Yyy/ZZ
Summary page 1
…asal/Epistaxis Pack KI 13585 (April 25, 2012) Polyganics NasoPore® Nasal Dressing, Model NDOX-YYY/ZZ K052099 (November 21, 2005) Hemostasis NexPak Intranasal Splint Class 1,Exempt Description Nasa…
Polyganics B.V.,2005—
*—Hemostasis NexPak Intranasal Splint
Named without a submission number
—

Also cleared against K113585: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 32 years and passes through 6 companies; a new generation was cleared every 5.3 years on median.
  • None of the 18 ancestors has a recall.
  • 2 other devices also cite its predicate K113585.

How does its category compare?

All LYA devices

LYA Splint, Intranasal Septal: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · LYA

1in 2025

2007: 12008: 22009: 12012: 12013: 22014: 52016: 12017: 22018: 22020: 12021: 12023: 12025: 1
2007high 5 (2014) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LYA

104in 2014

2014: 104 days median
2007high 104 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LYA

No recall names LYA since 2007.

Adverse event reports per year · LYA

1in 2025

2007: 22009: 52010: 22011: 162012: 162013: 12014: 42015: 282016: 282017: 102018: 192019: 52020: 62021: 192022: 82023: 172024: 72025: 1
2007high 28 (2015) · low 0 (2008)2025

MAUDE reports naming product code LYA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—02
20082—00
20091—05
20100—02
20110—016
20121—016
20132—01
2014510404
20150—028
20161—028
20172—010
20182—019
20190—05
20201—06
20211—019
20220—08
20231—017
20240—07
20251—01
20260—0—

What is it indicated for?

The ArthroCare NasaStent is intended to minimize bleeding and edema and to prevent adhesions between the septum and the nasal cavity. It is placed in the nasal cavity after surgery or trauma. NasaStern is constructed from absorbent CarboxyMethyl Cellulose (CMC) material.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K140992: Arthrocare Nasastent CMC Nasal Dressing.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K140992

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026